Two postdoctoral fellows in Mucosal Immunology
Göteborgs universitet / Apotekarjobb / Göteborg
Observera att sista ansökningsdag har passerat.
Visa alla apotekarjobb i Göteborg,
Mölndal,
Partille,
Kungälv,
Lerum eller i
hela Sverige Visa alla jobb hos Göteborgs universitet i Göteborg,
Partille,
Lysekil,
Uddevalla,
Vänersborg eller i
hela Sverige Two postdoctoral positions are available in the Mucosal Immunology group headed by Professor Nils Lycke at the Department of Microbiology & Immunology at the University of Gothenburg. The research in our group is financed by two EU-projects, the Swedish Foundation for Strategic Research, Knut and Alice Wallenberg Foundation, the Swedish Cancer Foundation and the Swedish Research Council. We focus on mucosal vaccines and adjuvant development and have a broad range of research topics within the group. These topics include mechanistic studies of adjuvants and how to improve vaccine efficacy by exploring nanoparticle formulations and fusion protein targeting of dendritic cells. Adaptive immunity is studied in the context of a universal flu vaccine and mucosal vaccines against norovirus infections. We are also internationally recognized for our work on gut IgA B cells and the unique functions of the germinal center reaction in Peyer's patches (see Nat Rev Immunol 12:593, 2012). Finally, a subgroup is dissecting mechanisms responsible for the powerful tolerogenic effects on autoimmune conditions that is conveyed by the CTA1R9K-DD tolerogenic platform, a project that is a collaboration between our academic group and the Toleranzia AB company in Gothenburg. The successful candidates will join a team of 12-15 members with expertise in state-of-the-art animal models for infectious diseases and autoimmunity, proteomics and systems biology approaches to adjuvant function.
The postdoctoral fellows will utilize state of the art animal models and in vivo/in vitro phenotypic and functional assays to assess the role of dendritic and follicular dendritic cells for the adjuvant and tolerogenic effects induced by enzymatically active CTA1-DD or inactive mutant CTA1R9K-DD. We are developing RNA seq technology to determine the consequences of vaccine induced protective immunity in the influenza and autoimmunity models. The candidate should be highly motivated, have the ability to work independently but also enjoy contributing and working within a team. Eligibility: An achieved doctoral degree is compulsory for a position as postdoctor at Göteborg University. The doctoral thesis shall be in a relevant area according to the specific position stated here. Since a position as postdoctor aims to give new holders of the doctorate the opportunity mainly to strengthen and develop their scholarly proficiency, we aim for those who have a doctoral degree not older than 3 years counting from last date of application. The successful candidates will have documented training in immunology (Ph.D), withconsiderable practical expertise in a broad range of immunological techniques, including multicolor flow cytometry, primary cell isolation and an in vivo/in vitro cellular assays and experience with in vivo murine models. The candidates should be highly motivated, have the ability to work independently, but also enjoy contributing and working within a team.
Please apply online:
www.gu.se/jobs. The application must include: -Application as a cover letter including a brief outline of prior research experience and scientific interests -CV with documented PhD exam - Diploma or other relevant merits - List of publications - 2 references with contact information
Varaktighet, arbetstid
Fixed-term employment, 2 years
Publiceringsdatum2017-03-02Så ansöker duSista dag att ansöka är 2017-03-23
Ange följande referens när du ansöker: PER 2017/79
Kontaktnils.lycke@microbio.gu.seFöretagGöteborgs universitet
AdressGöteborgs universitet
Box 100
40530 GÖTEBORG
KontorsadressUniversitetsplatsen 1
Jobbnummer 3352459
Observera att sista ansökningsdag har passerat.